Anchalee
Anchalee Jiemjit, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20110045554 | HETEROLOGOUS EXPRESSION OF EXTREMOPHILE HEAT SHOCK PROTEINS AND CHAPERONES IN MICROORGANISMS TO INCREASE TOLERANCE TO TOXIC COMPOUNDS - The invention provides methods and compositions for increasing tolerance of microorganisms to toxic agents, such as solvents; and for increasing production of solvents from solvent-generating microorganisms. The methods comprise engineering a microorganism of interest to express a heterologous heat-shock protein/chaperone, e.g., Group II chaperonin or a prefoldin such as γ-prefoldin, where the heterologous protein is from an extremophile, such as an archaean. | 02-24-2011 |
Anchalee Puengnim, Nurnberg DE
Patent application number | Description | Published |
---|---|---|
20140191903 | Radionavigation signal tracking device - A radionavigation signal tracking device comprises a first and a second tracking stage for radionavigation signals. The first tracking stage comprises a first carrier phase-locked loop. The latter produces a first error signal arising from a phase difference between the first carrier and its replica. The phase of the replica of the first carrier is adjusted with the first error signal. The second tracking stage comprises a second carrier phase-locked loop. The latter produces a second error signal arising from a difference between the first phase difference and a phase difference between the second carrier and the replica thereof. The phase of the replica of the second carrier is adjusted with the first and second error signals. | 07-10-2014 |
Anchalee Thanavaro, Definance, MO US
Patent application number | Description | Published |
---|---|---|
20120108593 | Extreme temperature aqueous decontamination composition - An extreme temperature decontamination composition such as a solution for destroying microorganisms, chemical warfare and bioterrorism agents is utilized that generally does not freeze at low temperatures down to about minus 25° F. and also has no significant evaporation or decomposition at temperatures up to about 120° F. The solution is effective against nerve agents and vesicants such as VX and HD, and various biological agents. The composition comprises a metallic salt of dichloroisocyanuric acid or dibromoisocyanuric acid, an aqueous solvent system comprising polar compounds such as water and an alkyl glycol, and a quasi hydrophilic compound. The composition can be formulated as a one part system wherein all components are blended together. | 05-03-2012 |